FDA Approved: COSOPT — Supplemental Application (Thea Pharma Inc.)

View source ↗

Summary

The FDA approved a supplemental application for COSOPT, the dorzolamide hydrochloride and timolol maleate combination, submitted by Thea Pharma Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Cosopt (dorzolamide/timolol)

Snippet

SUPPL AP for COSOPT (DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE)